Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Non-Current Deferred Tax Liability (2019 - 2025)

Ligand Pharmaceuticals' Non-Current Deferred Tax Liability history spans 14 years, with the latest figure at $22.7 million for Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 51.14% year-over-year to $22.7 million; the TTM value through Sep 2025 reached $22.7 million, down 51.14%, while the annual FY2024 figure was $32.5 million, 2.85% up from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2025 was $22.7 million at Ligand Pharmaceuticals, down from $32.2 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $75.6 million in Q4 2022 and bottomed at $22.7 million in Q3 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $32.5 million (2024), against an average of $40.2 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability soared 366.58% in 2021 before it plummeted 58.16% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $30.9 million in 2021, then skyrocketed by 144.95% to $75.6 million in 2022, then tumbled by 58.16% to $31.6 million in 2023, then increased by 2.85% to $32.5 million in 2024, then tumbled by 30.29% to $22.7 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Non-Current Deferred Tax Liability are $22.7 million (Q3 2025), $32.2 million (Q2 2025), and $29.4 million (Q1 2025).